KDR and neoplasm: Moreover, tumor growth in the ATC tumor-bearing nude mouse model was significantly inhibited by the anti-VEGFR2 targeted MSNs compared with that achieved using non-targeted MSNs and the 131I treatment with anti-VEGFR2 targeting MSNs significantly prolonged the survival of ATC tumor-bearing mice.